Collegium Pharmaceutical (COLL) EPS (Basic) Growth (5y) (2019 - 2026)
Collegium Pharmaceutical (COLL) EPS (Basic) Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Collegium Pharmaceutical | 889.75 Mn | 740.43 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.30% |
| Mar 31, 2026 | -1.26% |
| Dec 31, 2025 | 21.48% |
| Sep 30, 2025 | 25.02% |
| Jun 30, 2025 | 9.96% |
| Mar 31, 2025 | 41.94% |
| Dec 31, 2024 | 51.21% |
| Sep 30, 2024 | 29.10% |
| Jun 30, 2024 | 44.43% |
| Mar 31, 2024 | 37.67% |
| Dec 31, 2023 | 27.98% |
| Sep 30, 2023 | 16.48% |
| Jun 30, 2023 | 24.14% |
| Mar 31, 2023 | 2.18% |
| Dec 31, 2022 | 18.05% |
| Sep 30, 2022 | 15.14% |
| Jun 30, 2022 | 30.10% |
| Mar 31, 2022 | 15.56% |
| Dec 31, 2021 | 8.84% |
| Sep 30, 2021 | 16.33% |